Owl Labs partners with Westcoast to expand access to seamless hybrid meeting experiences in the UK and Ireland
11.5.2026 10:00:00 EEST | Business Wire | Press release
Owl Labs, a global leader in AI-powered, 360-degree video conferencing solutions, today announced a new UK and Ireland distribution partnership with Westcoast Limited, one of the country’s largest and most trusted IT distributors. The agreement will see Westcoast distribute the full range of Owl Labs’ award-winning Meeting Owl and Owl Bar products across the UK and Ireland, providing greater choice, availability, and dedicated support for resellers and end customers navigating the demands of hybrid work.
The partnership aims to address the technical setup challenges that plague meetings across the UK. Owl Labs’ recent State of Hybrid Work report found that nearly 8 in 10 workers (79%) lose time in meetings due to technical difficulties such as connecting to a meeting or setting up a camera. By making Owl Labs’ solutions simpler to source, deploy and support, the Westcoast partnership helps cut the ‘meeting tax’, reducing set‑up friction and getting meetings started on time.
The announcement follows the launch of the Meeting Owl 5 Pro earlier this year, Owl Labs’ newest 360-degree camera, speaker, and mic device. The Meeting Owl 5 Pro reimagines the centre-of-table experience for hybrid meetings with a solution purpose-built for enterprise organisations, delivering a seamless single-cable Bring Your Own Device (BYOD) experience. It is also now certified for Microsoft Teams, affirming that the device meets the highest standards demanded by IT leaders, ensuring optimal functionality within enterprise environments.
Westcoast, renowned for its strong vendor relationships and deep reseller network, will position Owl Labs’ products in its Unified Communications division alongside other leading collaboration technologies. This partnership expands Owl Labs’ footprint in the UK and Ireland, offering customers smooth access and faster delivery, while connecting partners with a trusted distributor deeply invested in video conferencing.
“Technology should not be a barrier to hybrid work,” said Frank Weishaupt, CEO, Owl Labs. “Our partnership with Westcoast represents a significant step in our UK growth strategy, aligning our products with a distributor that shares our dedication to customer success. Together, we are enabling seamless hybrid meetings, with technology that makes it easier than ever for organisations to build meeting spaces that work for everyone.”
Widening access to Owl Labs’ technology through Westcoast’s distribution network, including the newly-launched Meeting Owl 5 Pro and the award-winning Meeting Owl 4+, means that organisations can more easily create flexible, fully integrated meeting environments. In doing so, businesses can transform basic setups into seamless flexible ecosystems, allowing employees to focus on what really matters: communication and productivity.
“We are delighted to welcome Owl Labs to our Unified Communications portfolio,” said Sam Armstrong, Unified Communications Business Manager, Westcoast. “As demand for hybrid working continues to grow, our partners and customers are seeking reliable, intuitive solutions that drive productivity and collaboration. Owl Labs’ products are a perfect fit, and we look forward to working together to bring these market-leading solutions to businesses across the UK and Ireland.”
This agreement is non-exclusive and covers the full portfolio of Meeting Owl and Owl Bar devices. Owl Labs partners now have the choice to buy from Westcoast or the existing distribution channels. For more information on all Owl Labs products, visit owllabs.co.uk.
About Owl Labs
Owl Labs is the first company to build AI-powered, 360-degree video conferencing solutions for hybrid organisations. Its connected device system and Owl Intelligence System™ software make meetings more inclusive and collaborative by levelling the playing field between remote and in-room participants. The Meeting Owl® product line is the first AI-powered, WiFi-enabled, 360-degree camera, microphone and speaker that automatically zooms in on whoever’s speaking. Owl Labs has raised $47 million in funding and is based in Boston, with remote and hybrid employees all over the world. To learn more, visit www.owllabs.co.uk.
About Westcoast
Westcoast Limitedis the UK’s leading IT distributor, supplying a broad portfolio of hardware, software, and its own range of IT services to partners across the channel. The company works closely with vendors and resellers to deliver tailored solutions and drive innovation in the UK’s technology ecosystem. Further information can be found here: https://www.westcoast.co.uk/
Westcoast Limited and, all divisions, are part of ALSO Holding AG (ALSN.SW), Europe’s largest technology provider, giving partners access to a vast ecosystem of solutions, services and expertise, and extending its reach worldwide via PaaS partners.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260511571986/en/
Contacts
owluk@clarity.global
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Kiabi Selects Navan to Centralise Global Travel Program11.5.2026 10:00:00 EEST | Press release
Navan (NASDAQ: NAVN), the global AI-powered business travel and expense platform, today announced it has been selected by Kiabi, the French multinational fashion retailer, to consolidate its global travel with one unified platform. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260511547434/en/ Fashion retailer targets high employee adoption and efficiency with AI-powered travel platform To support its workforce of nearly 10,000 “Kiabers,” the retailer required a solution capable of providing an easy-to-use travel platform. Navan was selected due to its intuitive AI-powered interface and ability to integrate with Kiabi’s travel policies directly in-app. “Managing travel was becoming an administrative burden that slowed our teams down,” said Denise Maurice, Indirect Procurement Director at Kiabi. “We wanted to give our ‘Kiabers’ the freedom to book their own trips without getting bogged down in manual approvals. Navan gives t
Fujirebio Announces CE Marking of the Fully Automated Lumipulse® G pTau 217 Plasma Assay11.5.2026 10:00:00 EEST | Press release
H.U. Group Holdings Inc. and its wholly owned subsidiary Fujirebio today announced that Fujirebio Europe N.V. has obtained a CE certificate of the Lumipulse G pTau 217 Plasma assay under the Regulation (EU) 2017/746 on in vitro diagnostic medical devices (IVDR). This CLEIA (chemiluminescent enzyme immunoassay) test allows for the quantitative measurement of Tau phosphorylated at threonine 217 (pTau 217) in human plasma (K2EDTA). “With Lumipulse G NfL Blood and Lumipulse G pTau 217 Plasma now CE‑marked on our LUMIPULSE G platform, we are advancing a new era of neurology diagnostics—one where blood‑based biomarkers enable earlier, broader, and more accessible insights into Alzheimer’s disease and neurodegeneration.” said Christiaan De Wilde, CEO at Fujirebio Europe N.V. “By delivering fully automated and scalable solutions, we are helping clinicians move decisively toward more timely and informed decision‑making. This milestone underscores our long‑term vision to reimagine the diagnostic
Mevion Introduces the First Proton Therapy System Designed for a LINAC Vault at ESTRO 202611.5.2026 09:00:00 EEST | Press release
Proton therapy is entering the LINAC vault. At ESTRO 2026, Mevion Medical Systems will introduce the MEVION S250-FIT Proton Therapy System to the European radiation oncology community, the first proton therapy system designed for installation in a standard radiation therapy vault. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260507172087/en/ The MEVION S250-FIT™ Proton Therapy System Now both U.S. FDA-cleared and CE-marked under Regulation (EU) 2017/745, the S250-FIT creates a new pathway for cancer centers to bring proton therapy into existing LINAC-based treatment environments, aligning advanced proton capability with the infrastructure, workflows, and capital planning of modern radiation oncology. Stanford Medicine: First S250-FIT Installation On April 7, 2026, Stanford Medicine unveiled the world’s first S250-FIT installation, developed in collaboration with Leo Cancer Care. The system was fully installed within a stan
CORRECTING and REPLACING Samsung Epis Holdings Reports First Quarter 2026 Financial Results11.5.2026 08:10:00 EEST | Press release
Business Updates section, the first bullet of release dated April 23, 2026, at 10:04 p.m. PT/April 24, 2026, at 1:04 a.m. ET should read: In October 2025, Samsung Bioepis entered into a private label partnership with Cordavis for OSPOMYV™ (denosumab-dssb), a biosimilar to Prolia1. The updated release reads: SAMSUNG EPIS HOLDINGS REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS Samsung Epis Holdings (KRX: 0126Z0), an investment company dedicated to innovations in biopharmaceuticals and biotechnology, today announced its financial results for the first quarter of fiscal year 2026. “Samsung Bioepis delivered solid growth this quarter driven by continued momentum across our biosimilar portfolio," said Kyung-Ah Kim, President and Chief Executive Officer (CEO) of Samsung Epis Holdings. “We are further strengthening our position through new global partnerships and continued portfolio expansion. As we mark the 10th anniversary of the launch of our first biosimilar in Europe, we remain focused on b
Vedanta FY26 Profit Soars by 22% to $2.8 bn; Enters Demerger Phase11.5.2026 03:30:00 EEST | Press release
India-based Vedanta Limited (BSE: 500295 & NSE: VEDL), a global leader in metals, oil & gas, critical minerals, power and technology, announced its results for the fourth quarter and full year ended 31 March 2026. It has delivered its best-ever financial performance, driven by structurally strong businesses and disciplined execution. For the full year, Vedanta’s Profit stood at an all-time high of $2.8 bn, reflecting a 22% YoY increase and a profit of $1 bn in Q4 FY26, up nearly 90% YoY. Vedanta reported its highest-ever annual revenue of about $20 bn, up 15% YoY, with Q4 revenue at $5.6 bn, an increase of nearly 30% YoY. The Company maintained strong cost leadership, contributing to record EBITDA of $6.3 bn for FY26, up by about 30% YoY, with margins expanding to around 40%. Q4 EBITDA stood at $2.0 bn, up by nearly 60% YoY, with a margin of approximately 44%. The balance sheet strengthened further, with Net Debt/EBITDA improving to 0.95x, supported by strong cash generation. Underscor
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom